Intuity Medical increases its 3 -dollar serial fund to 55 million with an additional closure of $ 15 million. AdditionAutomatic (TM) of Intuity Medical, first fully integrated blood glucose control.
Intuity Medical, Inc., a private company that develops innovative technologies for the treatment of diabetes, announced today that it has closed an additional financing round of 15 million dollars, which carries the total financing of values of series 3 for the companyup to 55 million dollars.
Kck Group joins the main investor PTV Healthcare Capital and the subsidiaries of Luther King Capital Management as new investors, together with existing investors: Acuitive Medical Ventures, Investor Growth Capital, U.S.Venture Partners, Venrock and Versant Ventures.
Additional financing will help give infrastructure and commercial launch funds of the Pogo Blood Glucose Control System (®) Automatic (TM) of Intuity Medical, first completely integrated blood glucose control
Intuity Medical, Inc., a private company that develops innovative technologies for the treatment of diabetes, announced today that it has closed an additional financing round of 15 million dollars, which carries the total financing of values of series 3 for the companyup to 55 million dollars.
Kck Group joins the main investor PTV Healthcare Capital and the subsidiaries of Luther King Capital Management as new investors, together with existing investors: Acuitive Medical Ventures, Investor Growth Capital, U.S.Venture Partners, Venrock and Versant Ventures.
The Pogo® Automatic Blood Glucose Control System (TM) of Intuity Medical, which has received permission from the United States and Food Administration (FDA) in April 2016, is the first blood glucose meter and blood.Multiple test cartridge that provides automatic tests with lancet, blood collection and analysis in a single simple step without having strips and separate lancets.
By combining all the necessary blood glucose test supplies within a 10-test self-containing cartridge, Pogo provides an adequate and discreet solution for millions of patients who need to regularly check their blood glucose in the treatment of their diabetes.
The number of adults with diabetes reaches the impressive figure of 422 million worldwide, with the disease being the seventh cause of death in the United States.According to the American Diabetes Association, almost half of the 29 million patients in the United States have not achieved glycemic control in the treatment of diabetes.The loads associated with glucose control tests are among the reasons for the poor glycemic control;Many of the patients cite the lack of simplicity and discretion as main barriers to try their current meter.Unlike other meters, Pogo does not need the patient to use individual strips or a separate lancet device, which eliminates the option of having to carry and discard multiple supplies.This means that patients can carry out a glucose level test while they are underway or are in public sites.
To carry out a test, one patient has only to press the Pogo Test port, and pogo automatically click your finger, collect the blood sample and show the result after an countdown of four seconds.The test only needs a small blood sample of 0.25 microliters to analyze the value of glucose.After completing 10 tests, the cartridgeSelf-containing can be discarded properly, eliminating the need to have to use used lancets and strips.
"Additional funds will help marketing efforts in the supply of Pogo Automatic in the United States market for patients who have sought an adequate way to prove their glucose," said Emory Anderson, general director and CEO of Intuity Medical, Inc.
When combined with the intuity medical Patterns® diabetes treatment system, a cloud -based safe platform to manage glucose information, Pogo provides health care professionals and patients with a standard shared platform to detect and treatImportant behaviors and trends that impact general glucose control.
Abuity Medicalintuity Medical is committed to the simplification of diabetes administration, through the development of own and innovative technologies to address the common barriers of glucose tests.The Pogo of Intuity Medical system is the first blood glucose meter and multipro -shaped cartridge designed to automate the test in a single and simple stage, without the need for separate test supplies.The exclusive Pogo integrated design gives the patient the flexibility of performing the tests as often as recommended by his health care professional, with the purpose of helping in the daily administration of his diabetes.The current investors of the company are Acuitive Medical Ventures, Emergent Medical Partners, Investor Growth Capital, Kck Group, Luther King Capital Management, PTV Healthcare Capital, U.S.Venture Partners, Venrock and Versant Ventures.
